Therapeutic Research Protocol Dose: 1000 mcg / 1 mg (2 capsules) Duration: 6 8 weeks Frequency: 1 capsule twice daily, morning and evening Cycle Interval: 4 weeks off before repeating Goal / Description: Higher-dose oral regimen evaluated in models targeting tendon, ligament, and gut barrier repair
TB-500: C212H350N56O78S Sequence (AA) : BPC-157: GEPPPGKPADDAGLV
Intrinsic Factor Inhibiting Conditions Conditions such as autoimmune disease or pernicious anemia cause an inability to make the intrinsic factor that is essential for Vitamin B-12 absorption
Metformin, commonly prescribed for type 2 diabetes, is well-known to cause diarrhoea and is also associated with B12 deficiencymeaning patients may be taking both simultaneously
Dose increase protocol (every 4 weeks) One week before your planned dose increase, ensure you have adequate medication for the new dose level
chronic liver disease and hepatitis may present with elevated levels Renal impairment : Reduced clearance can contribute to accumulation, though this is rarely clinically significant Solid tumours : Certain malignancies, particularly hepatocellular carcinoma and metastatic disease, may elevate B12 levels [3] Evidence suggests that unexplained markedly elevated B12 levels without supplementation may sometimes be associated with underlying disease